怀化联邦快递公司业务查询 怀化联邦快递航空全球

 Federal Express Corporation, one of the world’s largest express transportation companies, has received the ‘Innovation in Clinical Supply Chain Logistics’ award at the Korea Biopharma Excellence Awards (KBEA) 2024[1]. This prestigious recognition highlights the company’s pioneering contributions and leadership in transforming the logistics landscape for the biopharmaceutical sector in South Korea and beyond.

怀化FedEx快递范围： 鹤城区FedEx 中方县FedEx 沅陵县FedEx 辰溪县FedEx 溆浦县FedEx 会同县FedEx 麻阳县FedEx 新晃县FedEx 芷江县FedEx 靖州县FedEx 通道县FedEx 洪江市FedEx

“FedEx is deeply honored to receive this award, which is a testament to our relentless commitment to excellence and innovation in the biopharmaceutical logistics field,” said Wonbin Park, managing director, FedEx Korea. “With the aging population and growing focus on health, the healthcare industry is rapidly expanding, making pharmaceutical and biotech logistics a critical component. Moreover, the increasing prevalence of precision medicines has highlighted the importance of cold chain logistics. FedEx strives to support these market changes by leveraging advanced technologies, coupled with our global expertise and extensive network, to make supply chains smarter for everyone. We are committed to facilitating rapid and secure delivery of clinical supplies knowing there’s a patient at the end of every delivery.”

Organized by IMAPAC, KBEA seeks to give recognition to exceptional biopharma experts, organizations, and technologies that drive excellence in biopharmaceutical development and manufacturing in South Korea. The winners are determined based on the results of more than 10,000 votes from South Korea and East Asia biopharma communities.